HEALTH SYSTEM SHOULD BE MAXIMUM DESIGNED FOR PATIENTS

08-10-2019 | 11:16

“Regulation in healthcare: pressing issues of circulating and supplying medicinal drug and medical products” Forum in Kazan brought together representatives of the government bodies, business and the expert community. Their common goal is to fin answers to the most acute challenges facing the healthcare system

 

The event at FAS Centre for Education and Methodology was opened by Stats-Secretary, Deputy Head of FAS Andrey Tsarikovskiy: “Healthcare is always full of discussions. There are not identical recipes and simple solutions”.

 

He pointed out that all recent efforts of FAS in the healthcare field are designed to profoundly reconsider the already existing initiatives. It concerns, for example, a draft law on medicinal drugs substitutability.

 

“Today, jointly with the colleagues from the Ministry of Healthcare we have been able to find a compromise enabling us to move forward. Without this law we cannot provide medicines to the population at normal prices”, emphasized Andrey Tsarikovskiy.

 

Head of FAS Department for Control over Social Sphere and Trade, Timophei Nizhegorodtsev summarized: “The Forum was masterminded as a working discussion of practical issues. Anyhow, there is an essence and if you understand it and can use it, you understand all regularities, you can build up a set of effective solutions. The objective of the today’s event is exactly to comprehend the essence in a calm environment. Ultimately, we must, based on fundamental knowledge and principles, change the current healthcare system, make it maximum oriented towards the absolute majority of the population of Russia. I am confident that through these discussions we will be able to move a step further to this goal to the benefit of our Motherland, the benefit of our people”.

 

Apart from public procurement of drugs and medical products, pricing, innovative models of drug supply, the Forum also discussed such issues typical for the healthcare sector as cartelization, advertising of medicinal drugs and dietary supplements.



Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide